C
Castle Biosciences, Inc.
CSTL · NASDAQ · Healthcare · 905M
Price · close
$34.20
+3.86% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.1×
Enterprise value / EBITDAEV/EBITDA
80.4×
Free cash flow yieldFCF yield
2.9%
Return on equityROE
-5.1%
Operating margin
-12.4%
Net debt / EBITDAbalance-sheet strength
-7.0×
Interest coverage
-497.8×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.